Dr Elena Elez speaks to ecancer about the integrated analysis of cell-free DNA BRAF mutant allele fraction and whole-exome sequencing in BRAFV600E metastatic colorectal cancer treated with BRAF negative antiEFGR positive/negative MEK inhibitors.

Initially, she talks about the background of the study. Dr Elez then discusses the methodology and results of the study.

In the end, she talks about how the results from this study can impact the future treatment of metastatic colorectal cancer.